结节性痒疹患者瘙痒对睡眠障碍的影响 - Suppr

Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis.

作者信息

Gwillim Eran C, Nattkemper Leigh, Yosipovitch Gil

机构信息

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 33136 Miami, FL, USA.

出版信息

Acta Derm Venereol. 2021 Mar 31;101(3):adv00424. doi: 10.2340/00015555-3778.

DOI:10.2340/00015555-3778

PMID:33704503

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9366710/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed10/9366710/322329f8bbc5/ActaDV-101-3-975-g001.jpg

相似文献

Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis.

Acta Derm Venereol. 2021 Mar 31;101(3):adv00424. doi: 10.2340/00015555-3778.

Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.

J Dermatolog Treat. 2022 May;33(3):1547-1553. doi: 10.1080/09546634.2020.1853024. Epub 2020 Dec 3.

Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.

J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1820-1825. doi: 10.1111/jdv.18377. Epub 2022 Jul 4.

Dermal Periostin: A New Player in Itch of Prurigo Nodularis.

Acta Derm Venereol. 2021 Jan 20;101(1):adv00375. doi: 10.2340/00015555-3702.

Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.

Actas Dermosifiliogr. 2022 Jul-Aug;113(7):674-684. doi: 10.1016/j.ad.2021.12.014. Epub 2021 Dec 23.

Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis.

Acta Derm Venereol. 2019 Mar 1;99(3):279-283. doi: 10.2340/00015555-3053.

INDIVIDUAL ARTICLE: Prurigo Nodularis: Current Clinicopathologic Overview and Psychodermatological Perspectives.

J Drugs Dermatol. 2023 Dec 1;22(12):SF365502s6-SF365502s11. doi: 10.36849/JDD.SF365502.

[Prurigo nodularis: its association with dermatoses and systemic disorders].

Hautarzt. 2014 Aug;65(8):697-703. doi: 10.1007/s00105-014-2755-x.

REMOVED: Plasma Steroids and Endocannabinoids Used as Biomarkers to Assess the Pruritus Severity of Patients With Prurigo Nodularis.

Actas Dermosifiliogr. 2022 Mar;113(3):244-253. doi: 10.1016/j.ad.2022.02.016. Epub 2022 Feb 8.

REMOVED: Plasma Steroids and Endocannabinoids Used as Biomarkers to Assess the Pruritus Severity of Patients With Prurigo Nodularis.

Actas Dermosifiliogr. 2022 Mar;113(3):T244-T253. doi: 10.1016/j.ad.2021.10.004. Epub 2021 Nov 1.

引用本文的文献

Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis.

Dermatol Ther (Heidelb). 2025 Jun;15(6):1405-1426. doi: 10.1007/s13555-025-01406-1. Epub 2025 Apr 23.

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.

JAMA Dermatol. 2025 Feb 1;161(2):147-156. doi: 10.1001/jamadermatol.2024.4796.

[Chronic prurigo].

Dermatologie (Heidelb). 2023 Nov;74(11):889-898. doi: 10.1007/s00105-023-05222-6. Epub 2023 Sep 18.

Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network.

JAAD Int. 2023 Jul 29;13:39-45. doi: 10.1016/j.jdin.2023.07.009. eCollection 2023 Dec.

The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.

Dermatol Ther (Heidelb). 2023 Jul;13(7):1587-1602. doi: 10.1007/s13555-023-00962-8. Epub 2023 Jun 17.

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.

EClinicalMedicine. 2023 Feb 3;57:101826. doi: 10.1016/j.eclinm.2023.101826. eCollection 2023 Mar.

本文引用的文献

The impact of prurigo nodularis on sleep disturbance and related impact: a systematic review.

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e815-e817. doi: 10.1111/jdv.16696. Epub 2020 Jun 25.

Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.

J Am Acad Dermatol. 2020 Jul;83(1):39-45. doi: 10.1016/j.jaad.2020.03.049. Epub 2020 Mar 27.

Treatment and Burden of Disease in a Cohort of Patients with Prurigo Nodularis: A Survey-based Study.

Acta Derm Venereol. 2020 Apr 21;100(8):adv00119. doi: 10.2340/00015555-3471.

Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study.

J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2373-2383. doi: 10.1111/jdv.16309. Epub 2020 May 12.

Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.

N Engl J Med. 2020 Feb 20;382(8):706-716. doi: 10.1056/NEJMoa1908316.

Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy.

J Dermatolog Treat. 2021 Jun;32(4):453-454. doi: 10.1080/09546634.2019.1659479. Epub 2019 Sep 2.

A Comprehensive Conceptual Model of the Experience of Chronic Itch in Adults.

Am J Clin Dermatol. 2018 Oct;19(5):759-769. doi: 10.1007/s40257-018-0381-6.

Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.

J Am Acad Dermatol. 2018 Sep;79(3):457-463.e5. doi: 10.1016/j.jaad.2018.04.044.

Nocturnal Pruritus: Prevalence, Characteristics, and Impact on ItchyQoL in a Chronic Itch Population.

Acta Derm Venereol. 2017 Apr 6;97(4):513-515. doi: 10.2340/00015555-2560.

Biopsychosocial Factors Associated with Prurigo Nodularis in Endogenous Eczema.

Indian J Dermatol. 2015 Sep-Oct;60(5):525. doi: 10.4103/0019-5154.164451.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献